AzTrials
AzTrials

UltrasoundNCT06725667

Ultrasound-Guided Transversalis Fascia Plane Block Versus Caudal Block for Postoperative Analgesia in Children Undergoing Inguinal Herniorrhaphy

A study testing Transversalis fascia plane block and Caudal block in people with Ultrasound and Transversalis Fascia Plane Block, run by Tanta University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to compare ultrasound-guided transversalis fascia plane block and caudal block for postoperative analgesia in children undergoing inguinal herniorrhaphy. Read more about this study

Who is it for?
Ages 1 year to 7 years
What is being tested?
Transversalis fascia plane block and Caudal block
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteEgypt
Study dates
11 Dec 2024to 6 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 7 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Age from 1 to 7 years.
  • Both sexes.
  • American Society of Anesthesiology (ASA) physical status I-II.
  • Scheduled for inguinal herniorrhaphy under general anesthesia (GA).

Who cannot join

  • Repeated surgeries.
  • Known allergic reactions to any of the study's drugs.
  • Infection at the site of block needle entry.
  • Bleeding diathesis.
  • Neurological disorders.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Tanta University

    Tanta, El-Gharbia, 31527

Other trials in Egypt

About this study

Official title: Ultrasound-Guided Transversalis Fascia Plane Block Versus Caudal Block for Postoperative Analgesia in Children Undergoing Inguinal Herniorrhaphy: A Randomized Controlled Non-Inferiority Trial

The aim of this study is to compare ultrasound-guided transversalis fascia plane block and caudal block for postoperative analgesia in children undergoing inguinal herniorrhaphy.

Read the detailed description

Surgical repair of inguinal hernia is one of the most common day-case surgeries in the pediatric population. It is associated with significant postoperative pain and discomfort.

Caudal block analgesia is a popular and reliable technique for lower abdominal surgeries and found to be safe and effective for providing intra and postoperative analgesia in pediatric patients.

transversal fascia plane block (TFPB) aims to provide analgesia for invasive procedures of the inguinal and sublingual areas by blocking the subcostal (T12), ilioinguinal (L1) and iliohypogastric (T12-L1) nerves. Several studies have reported TFPB as the analgesic method of choice for procedures involving the T12-L1 dermatome region, including iliac bone graft harvesting, cesarean section, and inguinal hernia repair

Being tested
Transversalis fascia plane block, Caudal block

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transversalis fascia plane blockOther

    Patients will receive transversalis fascia plane block after the induction of general anesthesia.

  • Caudal blockOther

    Patients will receive caudal block after the induction of general anesthesia.

Study groups in NCT06725667
Study groupRoleWhat they receive
Transversalis fascia plane block groupExperimentalPatients will receive transversalis fascia plane block after the induction of general anesthesia.
Receives: Other: Transversalis fascia plane block
Caudal block groupActive comparatorPatients will receive caudal block after the induction of general anesthesia.
Receives: Other: Caudal block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to the 1st rescue analgesia

    Time to the first request for the rescue analgesia (time from the end of surgery to first dose of paracetamol administrated).

    Measured: 24 hours postoperatively

Secondary outcomes (7)
  1. Total paracetamol consumption

    Each of the five items of the Face, legs, activity, cry, and consolability (FLACC) scale will be scared, ranging from 0 to 2, which will be then aggregated to obtain a total score ranging from 0 to 10. Higher scores on the scale indicated a higher level of pain intensity. If the FLACC scale exceeds three, IV paracetamol (15 mg/kg) will be given.

    Measured: 24 hours postoperatively

  2. Intraoperative fentanyl consumption

    Additional fentanyl bolus dosages of 1 µg/kg IV will be administered if heart rate or mean arterial blood pressure elevated more than 20% of the baseline (after exclusion of other causes than pain).

    Measured: Intraoperatively

  3. Degree of pain

    Degree of pain will be assessed using the Face, legs, activity, cry, and consolability (FLACC) scale. Each of the five items of the FLACC scale will be scared, ranging from 0 to 2, which will be then aggregated to obtain a total score ranging from 0 to 10. Higher scores on the scale indicated a higher level of pain intensity.

    Measured: 24 hours postoperatively

  4. Hear rate

    Hear rate will be recorded preoperatively, before performing of block, and every 15 min till the end of surgery.

    Measured: Every 15 min till the end of surgery (Up to 2 hours)

  5. Mean arterial pressure

    Mean arterial pressure will be recorded preoperatively, before performing of block, and every 15 min till the end of surgery.

    Measured: Every 15 min till the end of surgery (Up to 2 hours)

  6. Degree of patient's parents satisfaction

    Degree of patient's parents satisfaction will be assessed on a 5-point Likert scale patient satisfaction (1, extremely dissatisfied; 2, unsatisfied; 3, neutral; 4, satisfied; 5, extremely satisfied)

    Measured: 24 hours postoperatively

  7. Incidence of adverse events

    Incidence of adverse events such as bradycardia, hypotension, nausea, vomiting, respiratory depression, or any other complication related to block such as hematoma, neurological injury, deep visceral injury, or local anesthetic toxicity will be recorded.

    Measured: 24 hours postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Dec 2024
  2. Study start11 Dec 2024
  3. Primary completion6 Dec 2025
  4. Study completion6 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06725667
Sponsor's protocol ID
36264PR935/11/24
Status last verified
Dec 2025
First submitted
5 Dec 2024
Last updated
30 Dec 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Questions about this trial

What is this clinical trial studying?

A study testing Transversalis fascia plane block and Caudal block in people with Ultrasound and Transversalis Fascia Plane Block, run by Tanta University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to the 1st rescue analgesia (time frame: 24 hours postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in